Ardent Health (ARDT) EBIT Margin (2023 - 2026)

Ardent Health (ARDT) has reported EBIT Margin for 4 consecutive years, with 5.65% the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT Margin fell 188.0% year-over-year to 5.65%; the TTM figure through Mar 2026 stood at 8.06% (up 292.0% YoY), while the FY2025 annual figure was 12.59%, down 136.0% from the prior year.
• EBIT Margin came in at 5.65% for Q1 2026 at Ardent Health, up from 11.54% in the prior quarter.
• The five-year high for EBIT Margin was 22.35% in Q4 2023, with the low at 31.81% in Q4 2024.
• Average EBIT Margin over 4 years is 6.24%, with a median of 4.92% recorded in 2024.
• Across the five-year window, EBIT Margin slumped 5416 bps in 2024 and surged 2028 bps in 2025, its largest moves.
• Year by year, EBIT Margin stood at 22.35% in 2023, then tumbled by 242 bps to 31.81% in 2024, then jumped by 64 bps to 11.54% in 2025, then surged by 51 bps to 5.65% in 2026.
• According to Business Quant data, EBIT Margin over the past three periods registered 5.65%, 11.54%, and 12.74% for Q1 2026, Q4 2025, and Q3 2025 respectively.